APIC BIO Trademark

Trademark Overview

On Thursday, January 3, 2019, a trademark application was filed for APIC BIO with the United States Patent and Trademark Office. The USPTO has given the APIC BIO trademark a serial number of 88978375. The federal status of this trademark filing is REGISTERED as of Tuesday, September 1, 2020. This trademark is owned by Apic Bio, Inc.. The APIC BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of pharmaceutical preparations for gene therapy
apic bio

General Information

Serial Number88978375
Word MarkAPIC BIO
Filing DateThursday, January 3, 2019
Status700 - REGISTERED
Status DateTuesday, September 1, 2020
Registration Number6143791
Registration DateTuesday, September 1, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2019

Trademark Statements

NOT AVAILABLE"BIO"
Goods and ServicesDevelopment of pharmaceutical preparations for gene therapy

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 25, 2019
Primary Code042
First Use Anywhere DateSaturday, February 17, 2018
First Use In Commerce DateSaturday, February 17, 2018

Trademark Owner History

Party NameApic Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameApic Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameApic Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, January 7, 2019NEW APPLICATION ENTERED
Friday, January 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 21, 2019ASSIGNED TO EXAMINER
Friday, March 22, 2019NON-FINAL ACTION WRITTEN
Friday, March 22, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 22, 2019NON-FINAL ACTION E-MAILED
Wednesday, September 11, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 17, 2019ASSIGNED TO LIE
Wednesday, September 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 29, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 22, 2020TEAS STATEMENT OF USE RECEIVED
Friday, July 10, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 22, 2020TEAS REQUEST TO DIVIDE RECEIVED
Monday, June 22, 2020DIVISIONAL REQUEST RECEIVED
Monday, June 22, 2020USE AMENDMENT FILED
Friday, July 17, 2020DIVISIONAL PROCESSING COMPLETE
Friday, July 17, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 28, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, July 27, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 1, 2020REGISTERED-PRINCIPAL REGISTER
Monday, September 1, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

apic therapy gene preparations pharmaceutical development